American Century Companies Inc. lessened its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 18.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,345,761 shares of the semiconductor company’s stock after selling 313,702 shares during the period. American Century Companies Inc.’s holdings in Axcelis Technologies were worth $131,400,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the business. Reinhart Partners LLC. grew its stake in shares of Axcelis Technologies by 6.0% in the 3rd quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock worth $157,234,000 after buying an additional 91,788 shares in the last quarter. Primecap Management Co. CA raised its position in shares of Axcelis Technologies by 2.1% during the 2nd quarter. Primecap Management Co. CA now owns 852,296 shares of the semiconductor company’s stock valued at $59,397,000 after buying an additional 17,230 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after acquiring an additional 44,275 shares during the last quarter. Boston Partners grew its position in Axcelis Technologies by 42.3% in the second quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock worth $33,616,000 after acquiring an additional 141,004 shares in the last quarter. Finally, LSV Asset Management bought a new stake in Axcelis Technologies during the third quarter worth approximately $30,747,000. Institutional investors own 89.98% of the company’s stock.
Axcelis Technologies Trading Down 1.2%
ACLS stock opened at $82.61 on Monday. Axcelis Technologies, Inc. has a 12 month low of $40.40 and a 12 month high of $102.93. The firm’s 50-day moving average is $87.80 and its 200 day moving average is $85.82. The company has a market capitalization of $2.54 billion, a PE ratio of 21.80, a P/E/G ratio of 9.88 and a beta of 1.78. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.77 and a quick ratio of 3.11.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the company. B. Riley Financial decreased their price objective on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 18th. Bank of America increased their price target on Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a report on Tuesday, January 13th. Zacks Research downgraded Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research report on Friday, February 20th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. Finally, Wall Street Zen downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $101.50.
Get Our Latest Stock Report on Axcelis Technologies
Insider Buying and Selling at Axcelis Technologies
In other Axcelis Technologies news, EVP Gerald M. Blumenstock sold 3,034 shares of Axcelis Technologies stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the sale, the executive vice president directly owned 18,661 shares of the company’s stock, valued at $1,669,413.06. The trade was a 13.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jorge Titinger sold 2,000 shares of the company’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the completion of the sale, the director owned 7,477 shares of the company’s stock, valued at $643,395.85. This represents a 21.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 6,034 shares of company stock worth $523,522 over the last 90 days. 0.48% of the stock is currently owned by company insiders.
Axcelis Technologies Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
